Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |